Trials / Completed
CompletedNCT03781999
The Effect of a Combination of Orange- and Pomegranate Actives on Physical Fitness in Elderly People
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- BioActor · Industry
- Sex
- All
- Age
- 60 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to determine the effect of daily supplementation of a combined orange- and pomegranate extract for a period of 4 weeks on physical fitness compared to placebo. In this crossover study, participants will daily receive either a placebo or Actiful®, a supplement containing 500 mg orange extract and 200 mg pomegranate actives, for 4 weeks followed by a wash-out period of 4 to 8 weeks. Subsequently, the second intervention period of 4 weeks (active product or placebo) will take place. The product and placebo will be supplied in capsules that participants can ingest with a glas of water (daily, prior to breakfast).
Detailed description
Dietary habits and physical activity are two important components of a healthy lifestyle. Targeted nutritional interventions may improve health and stimulate physical activity. Both orange extracts and pomegranate concentrate have been shown to exert beneficial effects on health and exercise performance. However, the effects of a combination of the two extracts on exercise and physical activity have not been investigated yet. It is expected that this combination may be an effective dietary way to improve exercise performance, physical activity in the free-living state, and quality of life in a middle aged population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Actiful | supplement containing 500 mg orange extract and 200 mg pomegranate actives |
| OTHER | Placebo | Maltodextrin |
Timeline
- Start date
- 2018-06-25
- Primary completion
- 2019-01-17
- Completion
- 2019-01-17
- First posted
- 2018-12-20
- Last updated
- 2019-06-24
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT03781999. Inclusion in this directory is not an endorsement.